Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia

CONCLUSION: Circ-ANAPC7 was upregulated in newly diagnosed and relapsed AML. It may serve as potential biomarkers for AML patient's diagnosis and monitoring.PMID:34879367 | DOI:10.1159/000520446

Source: Acta Haematologica - December 8, 2021 Category: Hematology Authors: Ying Shen Yachun Jia Ru Zhang Hongli Chen Yuandong Feng Fangmei Li Ting Wang Ju Bai Aili He Yun Yang Source Type: research